BioSmart Statistics

Total Valuation

BioSmart has a market cap or net worth of KRW 74.56 billion. The enterprise value is 147.08 billion.

Market Cap	74.56B
Enterprise Value	147.08B

Important Dates

The last earnings date was Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

BioSmart has 25.27 million shares outstanding. The number of shares has decreased by -34.07% in one year.

Current Share Class	n/a
Shares Outstanding	25.27M
Shares Change (YoY)	-34.07%
Shares Change (QoQ)	-24.83%
Owned by Insiders (%)	24.78%
Owned by Institutions (%)	0.29%
Float	18.75M

Valuation Ratios

The trailing PE ratio is 586.30.

PE Ratio	586.30
Forward PE	n/a
PS Ratio	0.13
PB Ratio	0.58
P/TBV Ratio	0.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.92, with an EV/FCF ratio of -45.77.

EV / Earnings	1,156.55
EV / Sales	0.30
EV / EBITDA	4.92
EV / EBIT	6.78
EV / FCF	-45.77

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.41.

Current Ratio	1.73
Quick Ratio	0.87
Debt / Equity	0.41
Debt / EBITDA	2.33
Debt / FCF	-20.04
Interest Coverage	4.20

Financial Efficiency

Return on equity (ROE) is 0.75% and return on invested capital (ROIC) is 5.58%.

Return on Equity (ROE)	0.75%
Return on Assets (ROA)	4.65%
Return on Invested Capital (ROIC)	5.58%
Return on Capital Employed (ROCE)	10.49%
Revenue Per Employee	3.03B
Profits Per Employee	794,820
Employee Count	160
Asset Turnover	1.85
Inventory Turnover	7.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.69% in the last 52 weeks. The beta is 0.81, so BioSmart's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-13.69%
50-Day Moving Average	3,080.60
200-Day Moving Average	3,632.60
Relative Strength Index (RSI)	47.03
Average Volume (20 Days)	92,927

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSmart had revenue of KRW 484.31 billion and earned 127.17 million in profits. Earnings per share was 6.00.

Revenue	484.31B
Gross Profit	82.26B
Operating Income	19.46B
Pretax Income	7.06B
Net Income	127.17M
EBITDA	27.66B
EBIT	19.46B
Earnings Per Share (EPS)	6.00

Full Income Statement

Balance Sheet

The company has 20.84 billion in cash and 64.40 billion in debt, giving a net cash position of -43.56 billion or -1,723.28 per share.

Cash & Cash Equivalents	20.84B
Total Debt	64.40B
Net Cash	-43.56B
Net Cash Per Share	-1,723.28
Equity (Book Value)	158.45B
Book Value Per Share	5,123.11
Working Capital	56.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.71 billion and capital expenditures -6.92 billion, giving a free cash flow of -3.21 billion.

Operating Cash Flow	3.71B
Capital Expenditures	-6.92B
Free Cash Flow	-3.21B
FCF Per Share	-127.14

Full Cash Flow Statement

Margins

Gross margin is 16.99%, with operating and profit margins of 4.02% and 0.03%.

Gross Margin	16.99%
Operating Margin	4.02%
Pretax Margin	1.46%
Profit Margin	0.03%
EBITDA Margin	5.71%
EBIT Margin	4.02%
FCF Margin	n/a

Dividends & Yields

BioSmart does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	34.07%
Shareholder Yield	34.07%
Earnings Yield	0.17%
FCF Yield	-4.31%

Stock Splits

The last stock split was on September 20, 2010. It was a reverse split with a ratio of 0.16667.

Last Split Date	Sep 20, 2010
Split Type	Reverse
Split Ratio	0.16667

Scores

BioSmart has an Altman Z-Score of 3.11.

Altman Z-Score	3.11
Piotroski F-Score	n/a